# Neuronavigation Guided iTBS With Personalized Target for Depression

> **NCT05577481** · PHASE2 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 68 (actual)

## Conditions studied

- Depression

## Interventions

- **COMBINATION_PRODUCT:** sham iTBS combined with antidepressants
- **COMBINATION_PRODUCT:** iTBS combined with antidepressants

## Key facts

- **NCT ID:** NCT05577481
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-10
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-02-28
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05577481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05577481, "Neuronavigation Guided iTBS With Personalized Target for Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05577481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*